IndraLab

Statements

Mitomycin C inhibits NLRP3. 5 / 5
| 5
reach
"Further results indicated that MMC can inhibit the activation of the NLRP3 inflammatory signalling pathway and thus downregulate the expression of downstream molecules, including IL-18 and IL-1 beta."
31827916
reach
"Therefore, MMC injection can attenuate the activation of the NLRP3/Caspase-1 pathway, thus inhibiting fibroblast proliferation and vascular hyperplasia and reducing the rate of pterygium recurrence."
31827916
reach
"Based on the results, we considered the possibility that MMC suppresses the activation of the NLRP3/Caspase-1 pathway to weaken neovascularization and fibroblast proliferation in pterygium."
31827916
reach
"Local MMC Injection at a Low Dose Attenuates the Activation of the NLRP3/Caspase-1 Pathway in Pterygium Specimens."
31827916
reach
"Further results indicated that MMC can inhibit the activation of the NLRP3 inflammatory signalling pathway and thus downregulate the expression of downstream molecules, including IL-18 and IL-1beta."
31827916